Old Web
English
Sign In
Acemap
>
Paper
>
162P Long-term efficacy and genomic characteristics of patients with TRK fusion lung cancer treated with larotrectinib
162P Long-term efficacy and genomic characteristics of patients with TRK fusion lung cancer treated with larotrectinib
2021
V. Moreno Garcia
Jessica J. Lin
Jyoti D. Patel
Ulrik Lassen
Ben Solomon
Lee S. Rosen
Serge Leyvraz
D.S.W. Tan
John A. Reeves
G. Beckmann
M. Rudolph
J. Wierzbińska
Laura Dima
Nicoletta Brega
Shivaani Kummar
A. Drilon
Keywords:
Medicine
Lung cancer
Trk receptor
Oncology
Internal medicine
Term (time)
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]